Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0770
+0.0030 (4.05%)
Jul 3, 2025, 4:00 PM EDT
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $120.87 thousand as of July 3, 2025. Its market cap has decreased by -94.88% in one year.
Market Cap
120.87K
Enterprise Value
13.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 120.87K, a decrease of -99.86%. That is a compound annual growth rate of -75.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 120.87K | -91.24% |
| Dec 31, 2024 | 1.38M | 26.04% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | 62.11M | -26.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 823.67M |
| Nika Pharmaceuticals | 708.22M |
| Elite Pharmaceuticals | 639.84M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 557.29M |
| American Oncology Network | 418.01M |
| Northwest Biotherapeutics | 366.72M |